'Tax pharma companies if they fail to act on AMR', says Review chief Lord O'Neill
Vet Rec
.
2018 Jun 30;182(26):728.
doi: 10.1136/vr.k2835.
PMID:
29954991
DOI:
10.1136/vr.k2835
No abstract available
Publication types
News
MeSH terms
Animals
Anti-Bacterial Agents / therapeutic use
Antimicrobial Stewardship
Drug Discovery
Drug Industry* / economics
Drug Resistance, Bacterial*
Humans
Taxes*
United Kingdom
Substances
Anti-Bacterial Agents